Hypothesized mechanisms and sites of action of electroconvulsive therapy

Electroconvulsive and Neuromodulation Therapies

Volumn , Issue , 2009, Pages 75-93

  Michael, Nikolaus ^a,b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Department of Psychiatry III Evangelische Stiftung Tannenhof ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79951657181     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511576393.005     Document Type: Chapter

References (58)

1. Abrams, R. 1991. Seizure generalization and the efficacy of unilateral electroconvulsive therapy. Convuls Ther 7: 213-17.
2. Abrams, R. 2002. Electroconvulsive therapy, 4th edn. Oxford: Oxford University Press.
3. Aihara, M., Ida, I., Yuuki, N., et al. 2007. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlateswith alteration of neural activity in prefrontal cortex and limbic/paralimbic regions. Psychiatry Res 155: 245-56.
4. Baxter, L. R., Schwartz, J. M., Phelps, M. E., et al. 1989. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 46: 243-50.
5. Bench, C. J., Friston, K. J., Brown, R. G., et al. 1993. Regional cerebral blood flow in depression measured by positron emission tomography: The relationship with clinical dimensions. Psychol Med 23: 579-90.
6. Blumberg, H. P., Stern, E., Ricketts, S., et al. 1999. Rostral and orbital prefrontal dysfunction in the manic state of bipolar disorder. Am J Psychiatry 156: 1986-88.
7. Blumberg, H. P., Stern, E., Martinez, D., et al. 2000. Increased anterior cingulate and caudate activity in bipolar mania. Biol Psychiatry 48: 1045-52.
8. Blumenfeld, H., McNally, K. A., Ostroff, R. B., and Zubal, I. G. 2003. Targeted prefrontal cortical activation with bifrontal ECT. Psychiatry Res 123(3): 165-70.
9. Bolwig, T. G. and Madsen, T. M. 2007. Electroconvulsive therapy in melancholia: The role of hippocampal neurogenesis. Acta Psychiatr Scand Suppl (433): 130-5.
10. Bonne, O., Krausz, Y., Shapira, B., et al. 1996. Increased cerebral blood flow in depressed patients responding to electroconvulsive therapy. J Nucl Med 37(7): 1075-80.
11. Braitenberg, V. and Schüz, A. 1998. Cortex: Statistics and geometry of neuronal connectivity, 2nd edn. Berlin: Springer.
12. Chamberlin, E. and Tsai, G. E. 1998. A glutamatergic model of ECT-induced memory dysfunction. Harv Rev Psychiatry 5: 307-17.
13. Conca, A., Prapotnik, M., Peschina, W., and König, P. 2003. Simultaneous pattern of rCBF and rCMRGlu in continuation ECT: Case reports. Psychiatry Res 124(3): 191-8.
14. Drevets, W. C., Price, J. L., Simpson, J. R., et al. 1997. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386: 824-7.
15. Duman, R. S., Heniger, G. R., and Nestler, E. J. 1997. A molecular and cellular theory of depression. Arch Gen Psychiatry 54: 597-606.
16. Eranti, S., et al. 2007. A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression. Am J Psychiatry 164(1): 73-81.
17. Fink, M. 1990. How does convulsive therapy work? Neuropsychopharmacology 3: 73-82.
18. Fuster, J. M. 2001. The prefrontal cortex - an update: Time is of the essence. Neuron 30(2): 319-33.
19. Galynker, I. I., Weiss, J., Ongseng, F., and Finestone, H. 1997. ECT treatment and cerebral perfusion in catatonia. J Nucl Med 38(2): 251-4.
20. Garlow, S. J., Musselman, D. L., andNemeroff, C.B. 1999. The neurochemistry ofmood disorders: Clinical studies. In Neurobiology of mental illness (eds. Charney, D. S., Nestler, E. J., and Bunney, B. S.). New York: Oxford University Press, pp. 348-64.
21. Gray, J. R., Braver, T. S., and Raichle, M. E. 2002. Integration of emotion and cognition in the lateral prefrontal cortex. Proc Natl Acad Sci USA 99(6): 4115-20.
22. Harrison, P. J. 2002. The neuropathology of primary mood disorder. Brain 125: 1428-49.
23. Hasler, G., Van Der Veen, J. W., Tumonis, T., Meyers, N., et al. 2007. Reduced prefrontal glutamate/glutamine and GABA levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 64: 193-200.
24. Henry, M. E., Schmidt, M. E., Matochik, J. A., et al. 2001. The effects of ECT on brain glucose: A pilot FDG PET study. J ECT 17(1): 33-40.
25. Kohn, Y., Freedman, N., Lester, H., et al. 2007.99mTc-HMPAOSPECTstudy of cerebral perfusion after treatment with medication and electroconvulsive therapy in major depression. J Nucl Med 48(8): 1273-8.
26. Krystal, A. D., Coffey, C. E., Weiner, R. D., and Holsinger, T. 1998. Changes in seizure threshold over the course of electroconvulsive therapy affect therapeutic response and are detected by ictal EEG ratings. J Neuropsychiatry Clin Neurosci 10(2): 178-86.
27. Lamont, S. R., Pauls, A., and Stewart, C. A. 2001. Repeated electroconvulsive stimulation, but not antidepressant drugs, induces mossy fibre sprouting in the rat hippocampus. Brain Res 893: 53-58.
28. Lewis, D. A. and Levitt, P. 2002. Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 25: 409-32.
29. Madsen, T. M., Treschow, A., Bengzon, J., et al. 2000. Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry 47: 1043-9.
30. Maletzky, B.M. 1986. Conventional and multiple-monitored electroconvulsive therapy. A comparison in major depressive episodes. J Nerv Ment Dis 174(5): 257-64.
31. Manji, H. K., Drevets, W. C., and Charney, D. 2001. The cellular neurobiology of depression. Nat Med 5: 541-7.
32. McNally, K. A. and Blumenfeld, H. 2004. Focal network involvement in generalized seizures: New insights from electroconvulsive therapy. Epilepsy Behav 5(1): 3-12.
33. Mervaala, E., Könönen, M., Föhr, J., et al. 2001. SPECT and neuropsychological performance in severe depression treated with ECT. J Affect Disord 66(1): 47-58.
34. Michael, N., Erfurth, A., Ohrmann, P., et al. 2003a. Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression. Psychol Med 33(7): 1277-84.
35. Michael, N., Erfurth, A., Ohrmann, P., et al. 2003b. Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex. Psychopharmacology 168: 344-6.
36. Michael, N., Erfurth, A., Ohrmann, P., et al. 2003c. Neurotrophic effect of electroconvulsive therapy: A protonmagnetic resonance study of the left amygdalar region in severely depressed elderly patients. Neuropsychopharmacology 28: 720-5.
37. Milo, T. J., Kaufman, G. E., Barnes, W. E., et al. 2001. Changes in regional cerebral blood flow after electroconvulsive therapy for depression. J ECT 17(1): 15-21.
38. Navarro, V., Gastó, C., Lomeña, F., et al. 2004. Frontal cerebral perfusion after antidepressant drug treatment versus ECT in elderly patients with major depression: A 12-month follow-up control study. J Clin Psychiatry 65(5): 656-61.
39. Nemeroff, C. B., Bissette, G., Akil, H., and Fink, M. 1991. Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treatedwith electroconvulsive therapy. Br J Psychiatry 158: 59-63.
40. Nobler, M. S., Sackeim, H. A., Prohovnik, I., et al. 1994. Regional cerebral blood flow in mood disorders, III. Treatment and clinical response. Arch Gen Psychiatry 51(11): 884-97.
41. Nobler, M. S., Oquendo, M. A., Kegeles, L. S., et al. 2001. Decreased regional brain metabolism after ECT. Am J Psychiatry 158(2): 305-8.
42. Ottosson, J. O. 1960. Experimental studies of the mode of action of electroconvulsive therapy: Introduction. Acta Psychiatr Scand Suppl 35(145): 5-6.
43. Pfleiderer, B., Michael, N., Erfurth, A., et al. 2003. Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res 122(3): 185-92.
44. Post, R. M. and Weiss, S. R. B. 1999. Neurobiological models of recurrence of mood disorder. In Neurobiology of mental illness (eds. Charney, D. S., Nestler, E. J., and Bunney, B. S.). New York: Oxford University Press, pp. 365-84.
45. Rothman, D. L., Behar, K. L., Hyder, F., and Shulman, R. G. 2003. In vivo NMR studies of the glutamate neurotransmitter flux and neuroenergetics: Implications for brain function. Annu Rev Physiol 65: 401-27.
46. Sackeim, H. A. 1999. The anticonvulsant hypothesis of the mechanisms of action of ECT: Current status. J ECT 15(1): 5-26.
47. Sackeim, H. A., Decina, P., Portnoy, S., et al. 1987. Studies of dosage, seizure threshold, and seizure duration in ECT. Biol Psychiatry 22(3): 249-68.
48. Sackeim, H. A., Luber, B., Katzman, G. P., et al. 1996. The effects of electroconvulsive therapy on quantitative electroencephalograms. Relationship to clinical outcome. Arch Gen Psychiatry 53(9): 814-24.
49. Sanacora, G., Mason, G. F., Rothman, D. L., et al. 2003. Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry 160: 577-9.
50. Sapolsky, R. M. 2000. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57: 925-35.
51. Scott, A. 2002. Neuroscience. A mathematical primer. New York/Berlin/Heidelberg: Springer- Verlag, p. 352.
52. Sermet, E., Grégoire, M. D., Galy, G., et al. 1998. Paradoxical metabolic response of the human brain to a single electroconvulsive shock. Neurosci Lett 254(1): 41-4.
53. Shapira, B., Lidsky, D., Gorfine, M., and Lerer, B. 1996. Electroconvulsive therapy and resistant depression: Clinical implications of seizure threshold. J Clin Psychiatry 57(1): 32-8.
54. Sheline, Y. I., Sanghavi, M., Mintun, M. A., and Gado, M. D. 1999. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 19: 5034-43.
55. Swartz, C.M. 2000. Physiological response to ECTstimulus dose. PsychiatryRes 97(2-3): 229-35.
56. Takano, H., Motohashi, N., Uema, T., et al. 2007. Changes in regional cerebral blood flow during acute electroconvulsive therapy in patients with depression: Positron emission tomographic study. Br J Psychiatry 190: 63-8.
57. Thiéberge, J., Bartha, R., Drost, D. J., et al. 2002. Glutamate and glutamine measured with 4.0T proton MRS in never-treated patients with schizophrenia and healthy volunteers. Am J Psychiatry 159: 1944-6.
58. Uesugi, H., Toyoda, J., and Iio, M. 1995. Positron emission tomography and plasma biochemistry findings in schizophrenic patients before and after electroconvulsive therapy. Psychiatry Clin Neurosci 49(2): 131-5.